ProShare Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-28,146
| Closed | -$130K | – | 1674 |
|
|
2019
Q1 | $130K | Buy |
28,146
+137
| +0.5% | +$633 | ﹤0.01% | 1546 |
|
|
2018
Q4 | $98K | Sell |
28,009
-5,558
| -17% | -$19.4K | ﹤0.01% | 1475 |
|
|
2018
Q3 | $338K | Sell |
33,567
-994
| -3% | -$10K | ﹤0.01% | 1291 |
|
|
2018
Q2 | $250K | Sell |
34,561
-2,458
| -7% | -$17.8K | ﹤0.01% | 1489 |
|
|
2018
Q1 | $224K | Sell |
37,019
-6,047
| -14% | -$36.6K | ﹤0.01% | 1488 |
|
|
2017
Q4 | $414K | Buy |
43,066
+470
| +1% | +$4.52K | ﹤0.01% | 1232 |
|
|
2017
Q3 | $378K | Buy |
42,596
+3,451
| +9% | +$30.6K | ﹤0.01% | 1068 |
|
|
2017
Q2 | $495K | Sell |
39,145
-1,864
| -5% | -$23.6K | ﹤0.01% | 970 |
|
|
2017
Q1 | $431K | Sell |
41,009
-10,179
| -20% | -$107K | ﹤0.01% | 1064 |
|
|
2016
Q4 | $471K | Buy |
51,188
+3,713
| +8% | +$34.2K | 0.01% | 1109 |
|
|
2016
Q3 | $560K | Sell |
47,475
-8,661
| -15% | -$102K | 0.01% | 904 |
|
|
2016
Q2 | $726K | Buy |
56,136
+331
| +0.6% | +$4.28K | 0.01% | 821 |
|
|
2016
Q1 | $892K | Sell |
55,805
-5,548
| -9% | -$88.7K | 0.01% | 741 |
|
|
2015
Q4 | $1.76M | Buy |
61,353
+4,305
| +8% | +$123K | 0.02% | 550 |
|
|
2015
Q3 | $1.62M | Sell |
57,048
-2,993
| -5% | -$85.2K | 0.02% | 531 |
|
|
2015
Q2 | $2.16M | Sell |
60,041
-147
| -0.2% | -$5.28K | 0.03% | 490 |
|
|
2015
Q1 | $1.75M | Buy |
60,188
+9,596
| +19% | +$279K | 0.02% | 604 |
|
|
2014
Q4 | $1.07M | Buy |
50,592
+7,098
| +16% | +$150K | 0.01% | 821 |
|
|
2014
Q3 | $843K | Sell |
43,494
-7,806
| -15% | -$151K | 0.01% | 1132 |
|
|
2014
Q2 | $801K | Sell |
51,300
-13,414
| -21% | -$209K | 0.01% | 1272 |
|
|
2014
Q1 | $1.34M | Buy |
64,714
+35,329
| +120% | +$732K | 0.02% | 1053 |
|
|
2013
Q4 | $379K | Buy |
+29,385
| New | +$379K | 0.01% | 1110 |
|